CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +109.1% | 2,681 | -0.4% | 0.00% | – |
| Q2 2022 | $66,000 | -23.3% | 2,693 | -21.4% | 0.00% | – |
| Q1 2022 | $86,000 | -24.6% | 3,425 | +9.3% | 0.00% | – |
| Q4 2021 | $114,000 | +115.1% | 3,134 | +1.7% | 0.00% | – |
| Q3 2021 | $53,000 | +103.8% | 3,083 | +57.1% | 0.00% | – |
| Q2 2021 | $26,000 | -91.8% | 1,962 | -68.4% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | -21.5% | 6,215 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $405,000 | +128.8% | 6,542 | +102.2% | 0.00% | – |
| Q3 2020 | $177,000 | – | 3,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |